Back
Cidara Therapeutics Stock Price Chart
Legendary Investor: "It's Time to Buy These 3 Made-in-America Stocks"
He's now recommending these Three Stocks for Trump's New Industrial Boom.
Buy
77
CDTX
Cidara Therapeutics
Last Price:
$61.99
Seasonality Move:
2.01%
7 Day Trial
ALL ACCESS PASS
$
7
Why Trump Could Send These 3 Stocks Soaring
According to legendary investor Louis Navellier, these three "Made in America" stocks are set to benefit from this coming boom.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cidara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.24 | Sell |
| 20-day SMA: | 60.29 | Buy |
| 50-day SMA: | 45.29 | Buy |
| 200-day SMA: | 26.58 | Buy |
| 8-day EMA: | 55.62 | Buy |
| 20-day EMA: | 36.91 | Buy |
| 50-day EMA: | 18.8 | Buy |
| 200-day EMA: | 5.35 | Buy |
Cidara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.24 | Buy |
| Relative Strength Index (14 RSI): | 66.1 | Buy |
| Chaikin Money Flow: | 370249 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.08 - 63.48) | Buy |
| Bollinger Bands (100): | (16.51 - 49.81) | Buy |
Cidara Therapeutics Technical Analysis
| Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cidara Therapeutics Stock
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 62.00 while CDTX 8-day simple moving average is 62.24, which is a Sell signal.
-
The stock price of CDTX is 62.00 while Cidara Therapeutics 20-day SMA is 60.29, which makes it a Buy.
-
Cidara Therapeutics 50-day simple moving average is 45.29 while CDTX share price is 62.00, making it a Buy technically.
-
CDTX stock price is 62.00 and Cidara Therapeutics 200-day simple moving average is 26.58, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
77
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a BuyThe current Cidara Therapeutics [CDTX] share price is $62.00. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics Stock Info
Market Cap:
1.4B
Price in USD:
62.00
Share Volume:
424.8K
Cidara Therapeutics 52-Week Range
52-Week High:
66.95
52-Week Low:
10.14
Buy
77
Cidara Therapeutics (CDTX)
is a Buy
Cidara Therapeutics Share Price Forecast
-
What is the Cidara Therapeutics stock price today?The Cidara Therapeutics stock price is 62.00 USD today.
-
Will CDTX stock go up or go down?Cidara Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cidara Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics is not overvalued.
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 62.00 while CDTX 8-day exponential moving average is 55.62, which is a Buy signal.
-
The stock price of CDTX is 62.00 while Cidara Therapeutics 20-day EMA is 36.91, which makes it a Buy.
-
Cidara Therapeutics 50-day exponential moving average is 18.80 while CDTX share price is 62.00, making it a Buy technically.
-
CDTX stock price is 62.00 and Cidara Therapeutics 200-day simple moving average is 5.35, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics
Is Cidara Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $3.83 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.94 per share, and a decrease next year of $0.39 per share.
Technical Analysis of Cidara Therapeutics
Should I short Cidara Therapeutics stock?
-
CDTX Moving Average Covergence Divergence (MACD) indicator is 17.24, suggesting Cidara Therapeutics is a Buy
-
Cidara Therapeutics Relative Strength Index (RSI) is 66.1, which suggest Cidara Therapeutics is overbought
-
The Bollinger Bands (25) for Cidara Therapeutics is (53.08 - 63.48), which suggest Cidara Therapeutics is a Buy
-
The Bollinger Bands (100) for Cidara Therapeutics is (16.51 - 49.81), which suggest Cidara Therapeutics is a Buy
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.